Willingness to vaccinate against the coronavirus

How to cite

Thunstrom, Linda. 2020. "Willingness to vaccinate against the coronavirus." AEA RCT Registry. AEARCTR-0005576. https://doi.org/10.1257/rct.5576-1.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Linda Thunstrom*

* Primary investigator

Registry ID
AEARCTR-0005576
DOI
https://doi.org/10.1257/rct.5576-1.0
First registered
Last updated
Status
Completed
Trial dates
2020-03-19 – 2020-03-24
Countries
United States of America ()
Registry record
http://www.socialscienceregistry.org/trials/5576

Abstract

The purpose of this research is to examine how people would respond to a vaccine against the Coronavirus (COVID-19) and how that in turn would affect the length and severity of the Coronavirus outbreak in the U.S.

Specifically, subjects will get information about the estimated risks of the coronavirus, as well as an estimate of how effective a coronavirus vaccine might be, and thereafter state their willingness to vaccinate themselves, or any children in their household.

Given it is unclear at this point exactly what the risks are from the coronavirus in the U.S., we will vary information about the risks across subjects, such that they will be randomized into one of 8 information treatments. In other words, each subject will only face one of the treatments.

We foresee the project to deliver important information to policymakers on the willingness to vaccinate against the corona virus, once a vaccine has been developed. It is important to government agencies not only to ensure a vaccine is developed, but also to ensure the uptake of the vaccine is satisfactory. This project helps with the latter.

Intervention

Participants will be randomized into one of 8 treatments. In each treatment, they will receive different risk information about the corona virus, and thereafter asked about their willingness to vaccinate themselves and their family members.

The information will consist of the following (2x2) design for 4 treatments:
-High or low estimates of probability of catching the virus, based on most current information from the Centers for Disease Control and Prevention (CDC).
-High or low severity (risk of death) of the COVID-19, as determined by scientists.

Further, in an additional 4 treatments, the above information will be combined with:
Risk information that is lower, communicated by the White house.

Experimental design

Participants will be randomized into one of 8 treatments. In each treatment, they will receive different risk information about the corona virus, and thereafter asked about their willingness to vaccinate themselves and their family members.

The information will consist of the following (2x2) design for 4 treatments:
-High or low estimates of probability of catching the virus, based on most current information from the Centers for Disease Control and Prevention (CDC).
-High or low severity (risk of death) of the COVID-19, as determined by scientists.

Further, in an additional 4 treatments, the above information will be combined with:
Risk information that is lower, communicated by the White house.

Design details

Randomization method
Randomization by computer
Randomization unit
Individuals.
Observations
3000 individuals
Arms
3000/8=375 individuals
Primary outcomes
Share of people who agree to vaccinate

Cited by

No citation data available for this registration yet.

Keywords